ABCG2 is not only expressed by cancer cells, but also by small intestinal epithelial cells, renal proximal tubule epithelial cells, liver cells, and capillary endothelial cells in the brain, and it influences the pharmacokinetics of drugs that are its substrates [6,7]. This evidence concerns the gene ABCG2 and cancer.